Literature DB >> 18196508

Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B.

Valérie Paquet1, Astrid A Volmer, Erick M Carreira.   

Abstract

Novel cationic amphotericin B derivatives as highly potent antifungal agents are reported. These semi-synthetic derivatives of amphotericin B were elaborated through a series of modifications both on the nitrogen atom of the mycosamine and on the C-16 carboxylic acid moiety. The antifungal activity of the new conjugates was tested against Saccharomyces cerevisiae and also against nine different strains of Candida albicans and Candida glabrata, including an amphotericin resistant strain. High potency was observed in the case of polyamine derivatives bearing two 3-aminopropyl chains on the mycosamine. The evaluation of the biological properties also included the determination of the hemolytic activity of the compounds by measuring the EH50 values.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18196508     DOI: 10.1002/chem.200701237

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

Review 1.  Constructing molecular complexity and diversity: total synthesis of natural products of biological and medicinal importance.

Authors:  K C Nicolaou; Christopher R H Hale; Christian Nilewski; Heraklidia A Ioannidou
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564

2.  The in vitro characterization of polyene glycosyltransferases AmphDI and NysDI.

Authors:  Changsheng Zhang; Rocco Moretti; Jiqing Jiang; Jon S Thorson
Journal:  Chembiochem       Date:  2008-10-13       Impact factor: 3.164

3.  Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.

Authors:  Samusi A Adediran; Timothy P Day; Diptesh Sil; Matthew R Kimbrell; Hemamali J Warshakoon; Subbalakshmi S Malladi; Sunil A David
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

4.  Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.

Authors:  Joanna Boros-Majewska; Natalia Salewska; Edward Borowski; Sławomir Milewski; Sladjana Malic; Xiao-Qing Wei; Anthony J Hayes; Melanie J Wilson; David W Williams
Journal:  Med Microbiol Immunol       Date:  2014-06-13       Impact factor: 3.402

5.  Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group.

Authors:  Anna N Tevyashova; Evgenia N Olsufyeva; Svetlana E Solovieva; Svetlana S Printsevskaya; Marina I Reznikova; Aleksei S Trenin; Olga A Galatenko; Ivan D Treshalin; Eleonora R Pereverzeva; Elena P Mirchink; Elena B Isakova; Sergey B Zotchev; Maria N Preobrazhenskaya
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

6.  C2'-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells.

Authors:  Brandon C Wilcock; Matthew M Endo; Brice E Uno; Martin D Burke
Journal:  J Am Chem Soc       Date:  2013-06-03       Impact factor: 15.419

7.  Amphotericin B Tamed by Salicylic Acid.

Authors:  Yuming Yu; Peng Chen; Ming Gao; Wei Lan; Shijun Sun; Ziwei Ma; Rome Sultani; Yincang Cui; Muhammad Naveed Umar; Sher Wali Khan; Xiaodong Cai; Zhenjiang Liang; Hui Tan
Journal:  ACS Omega       Date:  2022-04-19

8.  Nontoxic antimicrobials that evade drug resistance.

Authors:  Stephen A Davis; Benjamin M Vincent; Matthew M Endo; Luke Whitesell; Karen Marchillo; David R Andes; Susan Lindquist; Martin D Burke
Journal:  Nat Chem Biol       Date:  2015-06-01       Impact factor: 15.040

9.  New Rimocidin/CE-108 Derivatives Obtained by a Crotonyl-CoA Carboxylase/Reductase Gene Disruption in Streptomyces diastaticus var. 108: Substrates for the Polyene Carboxamide Synthase PcsA.

Authors:  Leticia Escudero; Mahmoud Al-Refai; Cristina Nieto; Hartmut Laatsch; Francisco Malpartida; Elena M Seco
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

10.  Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.

Authors:  Tsai-Yu Lin; Christopher R Chin; Aaron R Everitt; Simon Clare; Jill M Perreira; George Savidis; Aaron M Aker; Sinu P John; David Sarlah; Erick M Carreira; Stephen J Elledge; Paul Kellam; Abraham L Brass
Journal:  Cell Rep       Date:  2013-11-21       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.